ImportRefusal LogoImportRefusal

Laborate Pharmaceuticals India Ltd.

⚠️ High Risk

FEI: 3005271729 • Paonta Sahib • INDIA

FEI

FEI Number

3005271729

📍

Location

Paonta Sahib

🇮🇳

Country

INDIA
🏢

Address

51 Indl. Area, , Paonta Sahib, , India

High Risk

FDA Import Risk Assessment

64.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
1
Unique Violations
12/3/2025
Latest Refusal
4/11/2024
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
97.7×20%
Frequency
18.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
12/3/2025
60WCB39THIABENDAZOLE (ANTHELMINTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2025
61WCB45FLUCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/11/2024
61PDY31GLIMEPIRIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Laborate Pharmaceuticals India Ltd.'s FDA import refusal history?

Laborate Pharmaceuticals India Ltd. (FEI: 3005271729) has 3 FDA import refusal record(s) in our database, spanning from 4/11/2024 to 12/3/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laborate Pharmaceuticals India Ltd.'s FEI number is 3005271729.

What types of violations has Laborate Pharmaceuticals India Ltd. received?

Laborate Pharmaceuticals India Ltd. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laborate Pharmaceuticals India Ltd. come from?

All FDA import refusal data for Laborate Pharmaceuticals India Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.